Newtaxel-A 40 mg/mL Solution For IV Injection
Pajjiż: Filippini
Lingwa: Ingliż
Sors: FDA (Food And Drug Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Docetaxel (As Trihydrate)
Disponibbli minn:
Qualimed Pharma Inc.; Distributor: Qualimed Pharma Inc.
INN (Isem Internazzjonali):
Docetaxel (As Trihydrate)
Dożaġġ:
40 mg/mL
Għamla farmaċewtika:
Solution For IV Injection
Unitajiet fil-pakkett:
USP Type I colorless vial x 0.5 mL (active) + USP Type I colorless glass vial x 1.8 mL (diluent) (Box of 1's); and 80 mg/ 2 mL: USP Type I colorless vial x 2 mL (active) + USP Type I colorless glass vial x 7 mL (diluent) (Box of 1's), USP Type I colorless vial x 0.5 mL (active) + USP Type I colorless glass vial x 1.8 mL (diluent) (Box of 1's); and 80 mg/ 2 mL
Manifatturat minn:
Korea United Pharm. Inc., Korea
Data ta 'l-awtorizzazzjoni:
2021-10-04
